Results 11 to 20 of about 567,888 (305)

Dysuria Associated with Non-Neoplastic Bone Hyperplasia of the Os Penis in a Pug Dog

Veterinary Sciences, 2021
A three-year-old male Pug presented with a three-year history of urolithiasis and repeated urethral obstruction. Biochemical analysis, ultrasonography, and retrograde urethrocystography revealed probable portosystemic shunt and incomplete urethral ...
Noritaka Maeta, Takako Shimokawa Miyama, Kenji Kutara, Teppei Kanda, Ikki Mitsui, Akihiro Ohnishi, Masahiro Miyabe, Yuki Shimizu, Kaori Saeki, Yasuhiko Okamura, Kazuaki Yamazoe   +10 more
doaj   +1 more source

Benign prostatic hyperplasia – what do we know?

BJU International, 2020
To present historical and contemporary hypotheses on the pathogenesis of benign prostatic hyperplasia (BPH), and the potential implications for current medical therapies.
C. Devlin, M. Simms, N. Maitland
semanticscholar   +1 more source

Inflammatory fibrous hyperplasia: a rare case in a child

RGO: Revista Gaúcha de Odontologia, 2019
This paper aims to describe an inflammatory fibrous hyperplasia case caused by chronic irritation due to poor dental positioning after trauma. An 11-year-old female patient was sent to a dental specialty center with the complaint of a soft tissue growth ...
Carla Vânia de Oliveira FIGUEIREDO, Ana Flávia Bissoto CALVO, Auremir Rocha MELO, José Carlos Pettorossi IMPARATO   +3 more
doaj   +1 more source

The rising worldwide impact of benign prostatic hyperplasia

BJU International, 2020
To describe the trend in the impact of lower urinary tract symptoms attributed to benign prostatic hyperplasia (LUTS/BPH) on a global scale using the Global Burden of Disease (GBD) database.
Bryn M. Launer, K. McVary, W. Ricke, G. Lloyd   +3 more
semanticscholar   +1 more source

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

Frontiers in Endocrinology, 2023
ObjectiveProgestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC).
Fengping Shao, Yinguang Li, Yunhe Zhao
doaj   +1 more source

Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency [PDF]

, 2009
Context: Familial glucocorticoid deficiency (FGD) is an autosomal recessive disorder resulting from resistance to the action of ACTH on the adrenal cortex.
Racine, M, Naville, D., Nurnberg, G., Green, J, Metherell, L. A., Nurnberg, P, Krone, NP, Krone, N. P., Arlt, W, Tomlinson, Jeremy, Achermann, JC, Halaby, G, Tomlinson, J. W., Clark, A. J. L., Krone, Nils, Naville, D, Berney, D. M., Begeot, M., Huebner, A., Halaby, G., Green, J., Berney, DM, Clark, AJ, Lin, L, Lin, L., Racine, M., Arlt, Wiebke, Achermann, J. C., Arlt, W., Nurnberg, G, Metherell, LA, Tomlinson, JW, Begeot, M, Huebner, A, Nurnberg, P., Clark, AJL   +35 more
core   +1 more source

A novel mutation L260P of the steroidogenic acute regulatory protein gene in three unrelated patients of swiss ancestry with congenital lipoid adrenal hyperplasia [PDF]

, 2005
Context: Lipoid congenital adrenal hyperplasia (CAH) is the most severe form of CAH leading to impaired production of all adrenal and gonadal steroids.
Maret, A, Achermann, J. C., Mullis, PE, Morel, Y., Leheup, B, Flück, Christa E., Portrat-Doyen, Stéphanie, Leheup, B., Achermann, JC, Mallet, D, Fluck, CE, Mullis, Primus-Eugen, Fluck, C. E., Maret, A., Morel, Yves, Mullis, P. E., Theintz, Gérald E., Portrat-Doyen, S., Theintz, GE, Leheup, Bruno, Mallet, D., Achermann, John C., Theintz, G. E., Morel, Y, Portrat-Doyen, S, Maret, Alexander, Mallet, Delphine   +26 more
core   +2 more sources

Anti-inflammatory activity of the lipid extract of Mytilus crassitesta

浙江大学学报. 农业与生命科学版, 2007
The anti-inflammatory activity of the Mytilus crassitesta lipid extract was investigated by using tissue hyperplasia assay and adjuvant arthritis model in rats.
YUAN Gao-feng, YAO Ting, LI Jiong, ZHANG Zhi-guo, LI Duo   +4 more
doaj   +1 more source

Current Treatment for Benign Prostatic Hyperplasia.

Deutsches Ärzteblatt International, 2020
BACKGROUND Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree.
A. Miernik, C. Gratzke
semanticscholar   +1 more source

Growth Patterns in the First Three Years of Life in Children with Classical Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening and Treated with Low Doses of Hydrocortisone [PDF]

, 2010
Background: Linear growth is the best clinical parameter for monitoring metabolic control in classical congenital adrenal hyperplasia (CAH). Objective: To analyze growth patterns in children with CAH diagnosed by newborn screening and treated with ...
Bonfig, W., Schmidt, H., Schwarz, H. P., Bonfig, W.;Schmidt, H.;Schwarz, H. P., H. Schmidt, W. Bonfig, Bonfig, W;Schmidt, H;Schwarz, HP, H.P. Schwarz   +7 more
core   +1 more source